| Product Name | Lemborexant - API |
| Product Code | DA-L199-a |
| Chemical name | Lemborexant |
| Synonyms | (1R,2S)-2-(((2,4-Dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide; Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S); |
| Impurity | NA |
| CAS Number | 1369764-02-2 |
| Alternate CAS # | NA |
| Molecular form | C22H20F2N4O2 |
| Appearance | White to Off-White Solid |
| Melting Point | NA |
| Mol. Weight | 410.42 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | Lemborexant is a novel orexin receptor antagonist and is used in the treatment of insomnia. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
